Tag Archives: MK-4166

Two Sides of Immune Checkpoint Control

Immune checkpoint control is the hottest area in cancer immunology.  Indeed, the checkpoint inhibitors have shown great activity in a variety of cancers.  This article http://online.wsj.com/article/PR-CO-20140506-908279.html)  summarizes 2 approaches that Merck is taking… Continue reading